Kruppel-like Factors (KLFs) in muscle biology

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 1, 2007, Pages 1-10

  Haldar, Saptarsi M ^a   Ibrahim, Osama A ^a   Jain, Mukesh K ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyocyte; Heart; KLF; Kruppel; Myocyte; Skeletal; Smooth muscle; Transcription

Indexed keywords

KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 10; KRUPPEL LIKE FACTOR 13; KRUPPEL LIKE FACTOR 15; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR 5; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; HEART MUSCLE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SMOOTH MUSCLE;

CARDIOVASCULAR DISEASES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUSCLE, SKELETAL; MUSCLE, SMOOTH; MYOCARDIUM;

EID: 34250167239     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.04.005     Document Type: Review

References (96)

1. Jain M.K., and Ridker P.M. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat. Rev., Drug Discov. 4 (2005) 977-987
2. Ventura-Clapier R., Mettauer B., and Bigard X. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc. Res. 73 (2007) 10-18
3. Libera L.D., and Vescovo G. Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: a chimaeric view of inflammation?. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 435-441
4. Finck B.N., and Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116 (2006) 615-622
5. McKinsey T.A., and Olson E.N. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J. Clin. Invest. 115 (2005) 538-546
6. Heineke J., and Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev., Mol. Cell Biol. 7 (2006) 589-600
7. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ. Res. 100 (2007) 607-621
8. Nuez B., Michalovich D., Bygrave A., Ploemacher R., and Grosveld F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375 (1995) 316-318
9. Akazawa H., and Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ. Res. 92 (2003) 1079-1088
10. Adhikari N., Charles N., Lehmann U., and Hall J.L. Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury. Curr. Atheroscler. Rep. 8 (2006) 252-260
11. Epstein J.A., and Parmacek M.S. Recent advances in cardiac development with therapeutic implications for adult cardiovascular disease. Circulation 112 (2005) 592-597
12. Perry C., and Soreq H. Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements. Eur. J. Biochem. 269 (2002) 3607-3618
13. Oettgen P. Regulation of vascular inflammation and remodeling by ETS factors. Circ. Res. 99 (2006) 1159-1166
14. Puigserver P., and Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24 (2003) 78-90
15. Wei D., Kanai M., Huang S., and Xie K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27 (2006) 23-31
16. Feinberg M.W., Lin Z., Fisch S., and Jain M.K. An emerging role for Kruppel-like factors in vascular biology. Trends Cardiovasc. Med. 14 (2004) 241-246
17. Suzuki T., Aizawa K., Matsumura T., and Nagai R. Vascular implications of the Kruppel-like family of transcription factors. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1135-1141
18. Turner J., and Crossley M. Basic Kruppel-like factor functions within a network of interacting haematopoietic transcription factors. Int. J. Biochem. Cell Biol. 31 (1999) 1169-1174
19. Bieker J.J. Isolation, genomic structure, and expression of human erythroid Kruppel-like factor (EKLF). DNA Cell Biol. 15 (1996) 347-352
20. Dang D.T., Zhao W., Mahatan C.S., Geiman D.E., and Yang V.W. Opposing effects of Kruppel-like factor 4 (gut-enriched Kruppel-like factor) and Kruppel-like factor 5 (intestinal-enriched Kruppel-like factor) on the promoter of the Kruppel-like factor 4 gene. Nucleic Acids Res. 30 (2002) 2736-2741
21. Nusslein-Volhard C., and Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 287 (1980) 795-801
22. Jackle H., Rosenberg U.B., Preiss A., Seifert E., Knipple D.C., Kienlin A., et al. Molecular analysis of Kruppel, a segmentation gene of Drosophila melanogaster. Cold Spring Harb Symp. Quant Biol. 50 (1985) 465-473
23. Zuo P., Stanojevic D., Colgan J., Han K., Levine M., and Manley J.L. Activation and repression of transcription by the gap proteins hunchback and Kruppel in cultured Drosophila cells. Genes Dev. 5 (1991) 254-264
24. Gloor H. Arch. Julius-Klaus-Stift. VererbForsch 25 (1950) 38-44
25. Miller I.J., and Bieker J.J. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol. Cell. Biol. 13 (1993) 2776-2786
26. Perkins A.C., Sharpe A.H., and Orkin S.H. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375 (1995) 318-322
27. Fisch S., Gray S., Heymans S., Haldar S.M., Wang B., Pfister O., et al. Kruppel-like Factor 15 is a Novel Regulator of Cardiomyocyte Hypertrophy. Proc Natl Acad Sci U.S.A. 104 (2007) 7074-7079
28. Shindo T., Manabe I., Fukushima Y., Tobe K., Aizawa K., Miyamoto S., et al. Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8 (2002) 856-863
29. Bhattacharya R., Senbanerjee S., Lin Z., Mir S., Hamik A., Wang P., et al. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J. Biol. Chem. 280 (2005) 28848-28851
30. Rowland B.D., Bernards R., and Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7 (2005) 1074-1082
31. SenBanerjee S., Lin Z., Atkins G.B., Greif D.M., Rao R.M., Kumar A., et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med. 199 (2004) 1305-1315
32. Parmar K.M., Larman H.B., Dai G., Zhang Y., Wang E.T., Moorthy S.N., et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J. Clin. Invest. 116 (2006) 49-58
33. Gray S., Wang B., Orihuela Y., Hong E.G., Fisch S., Haldar S., et al. Regulation of gluconeogenesis by Kruppel-like Factor 15. Cell Metab. 5 (2007) 305-312
34. Das H., Kumar A., Lin Z., Patino W.D., Hwang P.M., Feinberg M.W., et al. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6653-6658
35. Feinberg M.W., Cao Z., Wara A.K., Lebedeva M.A., Senbanerjee S., and Jain M.K. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J. Biol. Chem. 280 (2005) 38247-38258
36. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
37. Lavallee G., Andelfinger G., Nadeau M., Lefebvre C., Nemer G., Horb M.E., et al. The Kruppel-like transcription factor KLF13 is a novel regulator of heart development. EMBO J. 25 (2006) 5201-5213
38. Rajamannan N.M., Subramaniam M., Abraham T.P., Vasile V.C., Ackerman M.J., Monroe D.G., et al. TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: discovery and characterization of a novel signaling pathway. J. Cell. Biochem. 100 (2007) 315-325
39. Sogawa K., Imataka H., Yamasaki Y., Kusume H., Abe H., and Fujii-Kuriyama Y. cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Res. 21 (1993) 1527-1532
40. Gray S., Feinberg M.W., Hull S., Kuo C.T., Watanabe M., Sen-Banerjee S., et al. The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4. J. Biol. Chem. 277 (2002) 34322-34328
41. 2-induced apoptosis. Physiol. Genomics 29 (2007) 118-127
42. Czubryt M.P., and Olson E.N. Balancing contractility and energy production: the role of myocyte enhancer factor 2 (MEF2) in cardiac hypertrophy. Recent Prog. Horm. Res. 59 (2004) 105-124
43. Pikkarainen S., Tokola H., Kerkela R., and Ruskoaho H. GATA transcription factors in the developing and adult heart. Cardiovasc. Res. 63 (2004) 196-207
44. Xu J., Gong N.L., Bodi I., Aronow B.J., Backx P.H., and Molkentin J.D. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281 (2006) 9152-9162
45. Liang Q., De Windt L.J., Witt S.A., Kimball T.R., Markham B.E., and Molkentin J.D. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 276 (2001) 30245-30253
46. Molkentin J.D., and Markham B.E. Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo. J. Biol. Chem. 268 (1993) 19512-19520
47. Asano H., Li X.S., and Stamatoyannopoulos G. FKLF-2: a novel Kruppel-like transcriptional factor that activates globin and other erythroid lineage genes. Blood 95 (2000) 3578-3584
48. Song A., Chen Y.F., Thamatrakoln K., Storm T.A., and Krensky A.M. RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity 10 (1999) 93-103
49. Scohy S., Gabant P., Van Reeth T., Hertveldt V., Dreze P.L., Van Vooren P., et al. Identification of KLF13 and KLF14 (SP6), novel members of the SP/XKLF transcription factor family. Genomics 70 (2000) 93-101
50. Martin K.M., Metcalfe J.C., and Kemp P.R. Expression of Klf9 and Klf13 in mouse development. Mech. Dev. 103 (2001) 149-151
51. Feng D., and Kan Y.W. The binding of the ubiquitous transcription factor Sp1 at the locus control region represses the expression of beta-like globin genes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9896-9900
52. Zhang P., Basu P., Redmond L.C., Morris P.E., Rupon J.W., Ginder G.D., et al. A functional screen for Kruppel-like factors that regulate the human gamma-globin gene through the CACCC promoter element. Blood Cells Mol. Dis. 35 (2005) 227-235
53. Ahn Y.T., Huang B., McPherson L., Clayberger C., and Krensky A.M. Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes. Mol. Cell. Biol. 27 (2007) 253-266
54. Grepin C., Dagnino L., Robitaille L., Haberstroh L., Antakly T., and Nemer M. A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol. Cell. Biol. 14 (1994) 3115-3129
55. Subramaniam M., Harris S.A., Oursler M.J., Rasmussen K., Riggs B.L., and Spelsberg T.C. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res. 23 (1995) 4907-4912
56. Subramaniam M., Gorny G., Johnsen S.A., Monroe D.G., Evans G.L., and Fraser D.G. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol. Cell. Biol. 25 (2005) 1191-1199
57. Subramaniam M., Hefferan T.E., Tau K., Peus D., Pittelkow M., Jalal S., et al. Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene. J. Cell. Biochem. 68 (1998) 226-236
58. Tachibana I., Imoto M., Adjei P.N., Gores G.J., Subramaniam M., Spelsberg T.C., et al. Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J. Clin. Invest. 99 (1997) 2365-2374
59. Bensamoun S.F., Hawse J.R., Subramaniam M., Ilharreborde B., Bassillais A., Benhamou C.L., et al. TGFbeta inducible early gene-1 knockout mice display defects in bone strength and microarchitecture. Bone 39 (2006) 1244-1251
60. Tsubone T., Moran S.L., Subramaniam M., Amadio P.C., Spelsberg T.C., and An K.N. Effect of TGF-beta inducible early gene deficiency on flexor tendon healing. J. Orthop. Res. 24 (2006) 569-575
61. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 63 (2004) 423-432
62. Funnell A.P., Maloney C.A., Thompson L.J., Keys J., Tallack M., Perkins A.C., et al. Erythroid Kruppel-like Factor directly activates the basic Kruppel-like Factor gene in erythroid cells. Mol. Cell. Biol. 27 (2007) 2777-2790
63. Davis C.A., Haberland M., Arnold M.A., Sutherland L.B., McDonald O.G., Richardson J.A., et al. PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol. Cell. Biol. 26 (2006) 2626-2636
64. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84 (2004) 767-801
65. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
66. Ross R. Atherosclerosis-An inflammatory disease [see comments]. N. Engl. J. Med. 340 (1999) 115-126
67. Pislaru S., and Simari R.D. The translation of transcription. Circ. Res. 97 (2005) 1083-1084
68. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., and Clowes A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89 (1992) 507-511
69. Ferns G.A., Raines E.W., Sprugel K.H., Motani A.S., Reidy M.A., and Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253 (1991) 1129-1132
70. Wei J., Gorman T.E., Liu X., Ith B., Tseng A., Chen Z., et al. Increased neointima formation in cysteine-rich protein 2-deficient mice in response to vascular injury. Circ. Res. 97 (2005) 1323-1331
71. Hoshino Y., Kurabayashi M., Kanda T., Hasegawa A., Sakamoto H., Okamoto E., et al. Regulated expression of the BTEB2 transcription factor in vascular smooth muscle cells: analysis of developmental and pathological expression profiles shows implications as a predictive factor for restenosis. Circulation 102 (2000) 2528-2534
72. Nagai R., Suzuki T., Aizawa K., Shindo T., and Manabe I. Significance of the transcription factor KLF5 in cardiovascular remodeling. J. Thromb. Haemost. 3 (2005) 1569-1576
73. Sakamoto H., Sakamaki T., Kanda T., Hoshino Y., Sawada Y., Sato M., et al. Smooth muscle cell outgrowth from coronary atherectomy specimens in vitro is associated with less time to restenosis and expression of a key Transcription factor KLF5/BTEB2. Cardiology 100 (2003) 80-85
74. Bafford R., Sui X.X., Wang G., and Conte M. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia. Surgery 140 (2006) 289-296
75. Kawai-Kowase K., Kurabayashi M., Hoshino Y., Ohyama Y., and Nagai R. Transcriptional activation of the zinc finger transcription factor BTEB2 gene by Egr-1 through mitogen-activated protein kinase pathways in vascular smooth muscle cells. Circ. Res. 85 (1999) 787-795
76. Miyamoto S., Suzuki T., Muto S., Aizawa K., Kimura A., Mizuno Y., et al. Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol. Cell. Biol. 23 (2003) 8528-8541
77. Sun R., Chen X., and Yang V.W. Intestinal-enriched Kruppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation. J. Biol. Chem. 276 (2001) 6897-6900
78. Fujiu K., Manabe I., Ishihara A., Oishi Y., Iwata H., Nishimura G., et al. Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ. Res. 97 (2005) 1132-1141
79. Seo S.B., McNamara P., Heo S., Turner A., and Lane W.S. Chakravarti, Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104 (2001) 119-130
80. Dai X., and Segre J.A. Transcriptional control of epidermal specification and differentiation. Curr. Opin. Genet. Dev. 14 (2004) 485-491
81. Jaubert J., Cheng J., and Segre J.A. Ectopic expression of Kruppel-like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier. Development 130 (2003) 2767-2777
82. Segre J.A., Bauer C., and Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22 (1999) 356-360
83. Hamik A.L., Kumar Z., Balcells A., Sinha M., Sumita. Katz J., Feinberg M., et al. Kruppel-like Factor 4 regulates endothelial inflammation. J. Biol. Chem. 282 (2007) 13769-13779
84. Nakatake Y., Fukui N., Iwamatsu Y., Masui S., Takahashi K., Yagi R., et al. Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol. Cell. Biol. 26 (2006) 7772-7782
85. Liu Y., Sinha S., McDonald O.G., Shang Y., Hoofnagle M.H., and Owens G.K. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J. Biol. Chem. 280 (2005) 9719-9727
86. King K.E., Iyemere V.P., Weissberg P.L., and Shanahan C.M. Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J. Biol. Chem. 278 (2003) 11661-11669
87. Parmacek M.S. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ. Res. 100 (2007) 633-644
88. Du K.L., Ip H.S., Li J., Chen M., Dandre F., Yu W., et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol. Cell. Biol. 23 (2003) 2425-2437
89. Pipes G.C., Creemers E.E., and Olson E.N. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 20 (2006) 1545-1556
90. Wang Z., Wang D.Z., Pipes G.C., and Olson E.N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7129-7134
91. Martin K.M., Ellis P.D., Metcalfe J.C., and Kemp P.R. Selective modulation of the SM22alpha promoter by the binding of BTEB3 (basal transcription element-binding protein 3) to TGGG repeats. Biochem. J. 375 (2003) 457-463
92. Uchida S., Tanaka Y., Ito H., Saitoh-Ohara F., Inazawa J., Yokoyama K.K., et al. Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Kruppel-like factor, a novel zinc finger repressor. Mol. Cell. Biol. 20 (2000) 7319-7331
93. Gray S, Wang B, Sakuma M, Croce K, Fisch S, Haldar S, et al. Targeting of KLF15 reveals a critical role in the vascular smooth muscle cell response to injury (Abstract). AHA Scientific Sessions 2006; AOP.21.3a: presentation number 1393.
94. Ruiz-Gomez M., Romani S., Hartmann C., Jackle H., and Bate M. Specific muscle identities are regulated by Kruppel during Drosophila embryogenesis. Development 124 (1997) 3407-3414
95. Matsumoto N., Laub F., Aldabe R., Zhang W., Ramirez F., Yoshida T., et al. Cloning the cDNA for a new human zinc finger protein defines a group of closely related Kruppel-like transcription factors. J. Biol. Chem. 273 (1998) 28229-28237
96. Yamamoto J., Ikeda Y., Iguchi H., Fujino T., Tanaka T., Asaba H., et al. A Kruppel-like factor KLF15 contributes fasting-induced transcriptional activation of mitochondrial acetyl-CoA synthetase gene AceCS2. J. Biol. Chem. 279 (2004) 16954-16962